Search Results - David T. Teachey

Refine Results
  1. 1
    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)

    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) by David T. Teachey

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome by David T. Teachey

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Predicting relapse risk in childhood acute lymphoblastic leukaemia

    Predicting relapse risk in childhood acute lymphoblastic leukaemia by David T. Teachey, Stephen P. Hunger

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Diagnosis and Management of Autoimmune Cytopenias in Childhood

    Diagnosis and Management of Autoimmune Cytopenias in Childhood by David T. Teachey, Michele P. Lambert

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    T-cell acute lymphoblastic leukemia

    T-cell acute lymphoblastic leukemia by Elizabeth A. Raetz, David T. Teachey

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease

    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease by Karen L. Bride, David T. Teachey

    Published 2017
    Get full text Get full text
    Pré-impressão
    Save to List
    Saved in:
  7. 7
    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia

    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia by David T. Teachey, Ching‐Hon Pui

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children

    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children by David T. Teachey, David O’Connor

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome by Chelsea Kotch, David M. Barrett, David T. Teachey

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy

    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy by Andrew D. Hughes, David T. Teachey, Caroline Diorio

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Toxicity management for patients receiving novel T-cell engaging therapies

    Toxicity management for patients receiving novel T-cell engaging therapies by David M. Barrett, David T. Teachey, Stephan A. Grupp

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)

    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) by David T. Teachey, Alix E. Seif, Stephan A. Grupp

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies by David T. Teachey, Stephan A. Grupp, Valerie I. Brown

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies by Sarah K. Tasian, David T. Teachey, Susan R. Rheingold

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Cellular therapy: Immune‐related complications

    Cellular therapy: Immune‐related complications by Joseph H. Oved, David M. Barrett, David T. Teachey

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia

    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia by David T. Teachey, Stephen P. Hunger, Mignon L. Loh

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies by David Barrett, Valerie I. Brown, Stephan A. Grupp, David T. Teachey

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia by Shannon L. Maude, David T. Teachey, David L. Porter, Stephan A. Grupp

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies by Shannon L. Maude, David M. Barrett, David T. Teachey, Stephan A. Grupp

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL' by David T. Teachey, Michael R. Bishop, David G. Maloney, Stephan A. Grupp

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: